For Prelims: Schedule M (Drugs Rules, 1945), Grade A Clean Area, WHO Technical Report Series (TRS)
For Mains: GMP harmonisation, WHO TRS 1044, sterile manufacturing, regulatory alignment, pharmaceutical quality assurance
Source:PIB
5 facts for one-day exams
SSC, railway, police and teaching exams ask direct questions like these.
- Amendment proposed to Schedule M of the Drugs Rules, 1945.
- It revises microbial contamination limits for Grade A clean areas.
- The revision aligns with WHO TRS No. 1044, Annexure 2.
- Grade A areas are critical zones for sterile product handling.
- Nodal ministry: Ministry of Health and Family Welfare.
Why in the news?
The Union Ministry of Health and Family Welfare has proposed amendments to Schedule M of the Drugs Rules, 1945, to align microbial contamination limits in Grade A clean areas with WHO TRS No. 1044 standards. This harmonisation strengthens India's regulatory framework for sterile pharmaceutical manufacturing and ensures international quality benchmarks.
Summary
- Amendment to Schedule M (Drugs Rules, 1945) proposed to revise microbial contamination limits for Grade A clean areas.
- New limits aligned with WHO Technical Report Series (TRS) No. 1044, Annexure 2, on GMP for sterile pharmaceutical products.
Background
Schedule M of the Drugs Rules, 1945, prescribes Good Manufacturing Practices (GMP) for pharmaceutical units in India. Grade A clean areas are the most critical zones where sterile products are exposed. India's existing microbial limits for these areas differed from international standards set by WHO, prompting the need for revision.
Key Analysis and Impact
The amendment brings India's sterile manufacturing regulations in line with WHO TRS No. 1044, enhancing the quality and safety of injectables and other sterile drugs. It mandates investigation upon any microbial growth in Grade A areas, strengthening contamination control. This move boosts India's credibility as a global pharmaceutical supplier and supports export compliance.
Way Forward
After reviewing public comments, the Ministry will finalise the amendment. Implementation will require pharmaceutical companies to upgrade monitoring systems and protocols in Grade A zones. The revision is expected to reduce contamination risks and align Indian manufacturing with evolving global GMP standards, benefiting both domestic patients and export markets.
Background GK
Textbook concepts you need to understand this news
- Schedule M (Drugs Rules, 1945)
- A schedule under the Drugs and Cosmetics Rules, 1945, that prescribes the Good Manufacturing Practices (GMP) for pharmaceutical manufacturing units in India.
- Grade A Clean Area
- The highest cleanliness zone in sterile pharmaceutical manufacturing where exposed products, containers, and sterilised components are handled; requires the most stringent microbial and particle control.
- WHO Technical Report Series (TRS)
- A series of publications by the World Health Organization that provide technical guidelines and standards on various health topics, including Good Manufacturing Practices.
Facts to remember
Tap a card to see the answer. Try to recall it first.
How exams will ask this
- Data: Schedule M of Drugs Rules, 1945; WHO TRS No. 1044, Annexure 2
- Nodal Body: Ministry of Health and Family Welfare
- Legal Point: Drugs Rules, 1945, Schedule M
Common mistake:
Students may confuse Schedule M with other schedules under the Drugs and Cosmetics Rules (e.g., Schedule H for prescription drugs, Schedule X for narcotics). Also, the amendment is about Grade A areas, not all cleanroom grades.
Write these in mains answers
- GMP harmonisation, WHO TRS 1044, sterile manufacturing, regulatory alignment, pharmaceutical quality assurance
Stuck? Get it in one tap
Schedule M is a set of quality rules for medicine-making in India. The government wants to tighten the cleanliness standards in the most sterile parts of a factory (Grade A areas) to match global WHO rules. If any germs are found, the company must investigate. This helps ensure that injections and other sterile medicines are safe.
- Polity: Regulatory bodies and subordinate legislation
- Science and Technology: Pharmaceuticals and drug regulation
Related concepts: Schedule M (Drugs Rules, 1945), Grade A Clean Area, WHO Technical Report Series (TRS)
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which ministry is responsible for proposing amendments to Schedule M of the Drugs Rules, 1945?
Explanation: The amendment was proposed by the Union Ministry of Health and Family Welfare, which administers the Drugs and Cosmetics Act and Rules. The Ministry of Chemicals and Fertilizers oversees the Department of Pharmaceuticals, but drug regulation falls under Health and Family Welfare.
- Q2Hard
Consider the following statements regarding the proposed amendment to Schedule M:
- 1. The amendment aims to align microbial contamination limits for Grade A clean areas with WHO TRS No. 1044 standards.
- 2. Schedule M is part of the Drugs Rules, 1945.
- 3. The proposed Schedule M amendment was issued by the Ministry of Chemicals and Fertilizers.
Which of the statements given above is/are correct?
Explanation: 1. True: The proposal aligns Grade A microbial limits with WHO TRS No. 1044. 2. True: Schedule M is part of the Drugs Rules, 1945. 3. False: The proposing ministry is the Ministry of Health and Family Welfare.
- Q3Medium
Which WHO document forms the basis for the proposed revision of microbial contamination limits in Grade A areas?
Explanation: The proposed amendment references WHO Technical Report Series No. 1044, Annexure 2, on Good Manufacturing Practices for Sterile Pharmaceutical Products.
- Q4Medium
What is the primary objective of aligning India's Schedule M microbial limits with WHO guidelines?
Explanation: The core objective is to bring India's GMP requirements in line with international WHO standards, ensuring the safety and quality of sterile drugs. Cost increase may be a side effect but is not the goal; exports are expected to improve, not reduce; and the amendment does not affect OTC drug approvals.
Frequently asked questions
1. What is the proposed amendment to Schedule M about?
The Union Ministry of Health and Family Welfare has proposed revising microbial contamination limits for Grade A clean areas in sterile pharmaceutical manufacturing to align with WHO TRS No. 1044 standards.
2. Which WHO document is referenced in the Schedule M amendment?
The amendment references WHO Technical Report Series (TRS) No. 1044, Annexure 2, on Good Manufacturing Practices for Sterile Pharmaceutical Products.
3. What is a Grade A clean area in pharmaceutical manufacturing?
Grade A areas are the most critical clean zones where sterile products, containers, and sterilised components are exposed, requiring the highest level of microbial and particle control.
4. How can stakeholders submit feedback on the proposed amendment?
Objections and suggestions can be sent to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare, at the specified address or via email at drugsdiv-mohfw[at]gov[dot]in.
All sources
Original4 November 2026 · Read story


